Sernova (TSE:SVA) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sernova Corp., a biotech company advancing cell therapies for chronic diseases, has announced the appointment of biotech veteran David Paterson Ph.D. to its Board of Directors. Paterson’s extensive experience in corporate development and his biopharma industry knowledge are expected to bolster Sernova’s growth and its innovative Cell Pouch System technology, particularly in the type 1 diabetes sector.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.